YD Bio Limited Ordinary Shares
Status: Publicly traded
Last reviewed: October 2026
Direct answer
YD Bio Limited Ordinary Shares is publicly traded on NASDAQ under the ticker YDES.
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate...
Can you invest in YD Bio Limited Ordinary Shares?
Yes. YD Bio Limited Ordinary Shares is publicly traded on NASDAQ under the ticker YDES.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for YD Bio Limited Ordinary Shares
Detailed equity research is provided by MarketSnap.